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I.

Introduction

In the digital age, the rise of technology means many things to many people. For lawyers,
it means that legal research can be done entirely online, without ever entering a library or picking
up a Reporter.1 For doctors, it means that they can make house calls, without ever leaving their
office.2 The list goes on. Most importantly, for many people, it means that they can communicate
with just about anyone, anywhere in the world, instantaneously. Along with the plethora of
benefits that advances in technology bring, there is the accompanying risk of misuse. Because
“the amount of data created and collected is exponentially rising,” the average data breach now
affects more people than ever before.3

While data breaches have occurred for as long as

individuals and companies have maintained records and stored private information, they have
increased significantly in number and magnitude as more companies and individuals rely on
computers for communication, record-keeping, and administrative uses. 4 A data breach is best
defined as “an incident in which sensitive, protected, or confidential data has potentially been
viewed, stolen, or used by an individual unauthorized to do so.” 5 Breaches in the administration
of healthcare have become increasingly prevalent—the origins of which are complex to trace.
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Healthcare data breaches, in particular, are on the rise. 6 Over the past seven years, the
annual number of health data breaches has risen by seventy percent—with seventy-five percent of
those breached, lost, or stolen records resulting from “hacking or IT incident.” 7 This “nebulous
category created by the government” does not distinguish between malicious data theft (such as
phishing attempts and ransomware) and accidental loss (such as sending to an unintended
recipient).8 Unlike other data breaches, healthcare data breaches involve what is known as
“protected health information” (PHI).9 PHI is any personally “identifiable health information that
is used, maintained, stored, or transmitted by . . . [a] healthcare provider, health plan or insurer, or
a healthcare clearinghouse – or a business associate” of one of those entities. 10 It includes past,
current, and future health information related to the administration of care or payment for care,
regardless of the form in which it is kept.11 Importantly, this includes both physical and electronic
records, as well as spoken information. 12 “Essentially all health information is considered PHI
when it includes individual identifiers,” such as patient names, Social Security numbers, driver’s
license numbers, birth dates, telephone numbers, or e-mail addresses. 13
In recent years, more healthcare providers have begun implementing Electronic Health
Records (EHR) into their practices—and in doing so, patients have received many benefits. 14 By
making health records available to patients in a digital format, patients can more easily access the
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information, the information can be updated more quickly, and patients can be in charge of taking
the necessary steps to safeguard their own health.15 Not only can they track their visits, but they
can view test results and cross-reference the information uploaded by their doctors. Studies have
similarly shown that when patients are engaged in other ways, such as being able to schedule and
confirm appointments electronically or through text message, they are more responsive and less
likely to no-show to an appointment.16 In response to these kinds of integration efforts by
providers, there has been a push to develop other methods of health information technology. 17
Online portals and other new technologies have proven increasingly effective at getting patients
more involved in their care, leading to better outcomes.18 While patients typically wait to hear
from doctors until they are able to call them to deliver test results or until they have an appointment
to see the doctor next, this method of making data available online allows patients to access their
health information in real-time—rather than being at the mercy of a doctor’s hectic schedule.
Despite the obvious ways in which technology has advanced and become integrated into
the administration of healthcare, the legal safeguards for cybersecurity matters have not progressed
as rapidly. The first federal law created to address mounting concerns was the Health Insurance
Portability and Accountability Act of 1996 (HIPAA). 19 HIPAA is commonly known as the Privacy
Rule, which requires, among other things, that those in possession of patient data take measures to
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protect it from accidental exposure or malicious theft. 20 If a patient’s information is compromised
or exposed during a data breach, that individual has certain rights and remedies. 21 While there is
no private right of action under HIPAA, which would allow an individual patient to sue an entity,
a patient may report the violation to the Secretary of Health and Human Services, who can then
bring an enforcement action.22 HIPAA does not preempt state laws that give rise to a private cause
of action, and many courts hold that failure to comply with HIPAA serves as evidence that a
physician failed to act reasonably, thus deviating from the standard of care. 23 In addition, a covered
entity that is aware of a breach has a duty to inform patients that the security of their health
information has been compromised.24
Following this trend toward electronically stored information and in furtherance of the goal
to improve patient access and engagement, the Center for Medicare and Medicaid Services (CMS)
proposed and recently passed an interoperability rule.25 Interoperability has many technical
definitions but put most simply, it “is the ability of two or more systems to exchange information
and to interpret and use that information.” 26 The purpose of the rule is “to move the health care
ecosystem in the direction of interoperability,” and to signal CMS’ commitment to improving
access to, and the quality of, healthcare information.27 The Final Rule seeks to prioritize the
availability of the information necessary for patients to make informed health care decisions.
Ideally, the rule does so without increasing the burden on health care providers and payers. 28 In
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application, the interoperability rule purports to give patients access to their health information by
requiring providers and insurers to compile that information into one EHR, made available through
an application programming interface (API).29 An API is a system by which “third party software
applications connect to make the data available to patients.” 30 The “open API”31 would include
both medical information (such as test results and diagnoses) as well as healthcare plan information
(such as a provider directory and claims data). 32 While all of this information is certainly available
to patients through various platforms, the task of collecting this data “can be burdensome and
frustrating to the consumer.”33
Although the final rule’s framework under CMS’ rule for increasing patient access to EHRs
serves a worthwhile and meaningful purpose, its implementation is more complicated, if not
entirely undermined by stringent state privacy laws. This Comment proposes that in order for this
interoperability rule to succeed at increasing patient access to health data without putting patients
at an increased risk of data breaches, Congress should amend the definition of “covered entities”
to include the third-party applications that will collect and maintain the patient health data.
Additionally, in the absence of the implementation of a Federal Privacy statute, Congress should
create a private right of action under HIPAA to ensure that patients who do suffer adverse effects
from a data breach are not without recourse. Section II of this Comment addresses past efforts to
promote interoperability and the ways in which such efforts have progressed toward, but ultimately
fell short of, the ultimate goal of interoperability. Section III of this Comment discusses the current
efforts and strategy on which the rule relies. Section IV addresses the benefits of interoperability,
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while Section V discusses the barriers (both potential and actual) impeding the rule’s
implementation. Section VI adds other considerations which may complicate compliance with the
rule, and Section VII concludes with proposed solutions to the problems that will arise. This
Comment will not address the cybersecurity issues posed by implementation but will instead focus
on the practical problems posed by attempts at compliance with both state laws and the CMS rule
given that no federal privacy law exists. Rather than advocating for a federal privacy law, the
proposed solutions focus on ways to amend HIPAA.
II.

Past Efforts to Promote Interoperability

This rule is not the first effort by CMS and Congress to achieve interoperability, but it is
the most recent effort to achieve it on a widespread scale. While it is certainly a revolutionary
measure, this newfound emphasis is also a long time coming. CMS and Congress have worked
toward a rule such as this by passing acts that play a key role in incentivizing providers to integrate
technology into their practices.
In 2009, Congress implemented the Health Information Technology for Economic and
Clinical Health Act (HITECH),34 which provided an opportunity to move interoperability forward
by “authorizing CMS to make incentive payments to eligible professionals, eligible hospitals and
critical access hospitals, and Medicare Advantage (MA) organizations to promote the adoption
and meaningful use of certified electronic health record technology (CEHRT).” 35 It also codified
the Office of the National Coordinator for Health Information Technology (ONC). 36 This
codification is significant because it bestowed regulatory authority upon the newly created agency
and allowed it to enforce these measures in a way that had not previously occurred. This was a

34

42 U.S.C.S. § 17932 (LexisNexis, Lexis Advance through Public Law 116–65, approved October 9, 2019).
84 Fed. Reg. 7610, 7612.
36
42 U.S.C.S. § 17932 (LexisNexis, Lexis Advance through Public Law 116–65, approved October 9, 2019).
35

7

crucial move toward the integration of interoperability because it allowed CMS to incentivize
providers to join in the efforts while offering its own guidance and standards. It involved three
stages of implementation, allowing providers to integrate technology at a gradual pace. Stage 1
created a foundation for the EHR Incentive Programs by enacting requirements for capturing
clinical data electronically, which included the requirement to provide patients with electronic
copies of health information.37 Stage 2 focused on advancing clinical processes and “ensuring that
the meaningful use of EHRs supported the aims and priorities of the National Quality Strategy.” 38
Stage 2 criteria encouraged the use of CEHRT for continuous quality improvement at the point of
care and the exchange of information in the most structured format possible.” 39 “Stage 3 focuses
on using CEHRT to improve health outcomes.” 40
The federal government has spent over $35 billion under these EHR Incentive Programs,
and while seventy-eight percent of physicians 41 and ninety-eight percent of hospitals42 now use a
certified EHR system, there has been very limited progress toward the implementation of an API,
or a method to share system-wide data.43 Because these incentivization programs were only
partially successful, more changes were necessary. In 2010, ONC established a set of initial
standards for the temporary certification program. 44 In 2011, the ONC changed those standards to
create a Permanent Certification Program, showing the continued commitment of the government
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to prioritize interoperability in a meaningful and practical way. 45 Given the amount of money that
the federal government has spent promoting interoperability and giving providers an opportunity
to pursue it themselves, it makes sense that the rule codifies and mandates these practices.
Congress enacted another important piece of legislature, the Medicare Access and CHIP
Reauthorization Act (MACRA),46 in April of 2015.47 The stated aim of MACRA was to “achieve
widespread exchange of health information through interoperable CEHRT nationwide.” 48 The Act
defines interoperability as “the ability of two or more health information systems or components
to exchange clinical and other information and to use the information that has been exchanged
using common standards as to provide access to longitudinal information to facilitate coordinated
care and improved patient outcomes.”49 Congress declared, in MACRA, that it was a national
objective to achieve widespread exchange of health information through interoperable certified
EHR technology nationwide by December 31, 2018.50 Based on the response to MACRA, ONC
identified two metrics for measuring interoperability.51 The first measure is the proportion of
health care providers who electronically engage in “sending, receiving, finding, and integrating
information received from outside sources” as opposed to those which are not. 52 The second
measure is “the proportion of health care providers who report using the information they
electronically receive from outside providers and sources for clinical decision-making.” 53 ONC

45
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stated in 2018 update to Congress that it would continue to measure and evaluate performance
according to these measures, keeping a keen eye on policy changes being implemented under the
21st Century Cures Act.54
III.

Current Efforts

In recent years, there has been a great deal of legislation that has further shaped the health
privacy landscape for payors, providers, and patients. In April 2018, EHR Incentive Programs and
the MIPS Advancing Care Information Performance category became “Promoting Interoperability
Programs” as “just one part of the CMS strategic shift in focus to advancing health IT and
interoperability.”55 21st Century Cures Act56 Section 4003 defines interoperability with respect to
health IT as “technology that enables the secure exchange of electronic health information from,
other health IT without special effort on the part of the user.” 57 It also provides for “complete
access, exchange, and use of all electronically accessible health information for authorized use
under applicable state or federal law and does not constitute information blocking as defined in
section 3022(a).”58 Information blocking refers to any practice that a provider knows or should
know “is likely to interfere with, prevent, or materially discourage access, exchange, or use of
electronic health information.”59 The two practices can be in tension, but this bill promotes and
funds the acceleration of research into methods for prevention and cures for serious illnesses—for
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which it is aptly named.60 While the bill is largely about funding research, it contains provisions
about information blocking and interoperability.61
Since its implementation, the ONC has introduced another proposed rule that outlines
seven main exceptions—situations in which activities that would otherwise constitute information
blocking are exempt from that characterization. 62 The full effect of these exceptions has not yet
been realized, as they are part of a rule that will go into effect in 2020—the same time as the
interoperability rule.63 It is somewhat difficult to recognize the trend toward creating more
leniency in the enforcement of the act. In May 2019, the Health Innovation Alliance called on
ONC to “go back to the drawing board” and rework the proposal. 64 The group said the seven
exceptions “contain too many loopholes which would result in extensive litigation before there can
be meaningful enforcement of the 21st Century Cures Act prohibition on information blocking.” 65
CMS has not, as of yet, provided more guidance on the proposal.
The interoperability rule arguably works with the 21st Century Cures Act through
requirements that prevent information blocking.66 Information blocking works both to protect
patient data and to limit the liability of providers in charge of uploading that data. 67 But the

60
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interoperability rule extends the requirement to make data available by focusing heavily on APIs,
and simultaneously focusing on data privacy.68 CMS believes that because the APIs have
standardized technology, are technically transparent, and are implemented in a pro-competitive
manner, they will allow for meaningful and convenient access to electronic health records. 69 If the
API technologies are standardized, it will be easier for payors (insurers) to update the information
and for patients to not only access the information but also to understand it. 70
To promote transparency, “CMS is proposing to require that API-documentation be
publicly accessible – meaning any individual using commonly available technology to browse the
internet could access the information without any preconditions or additional steps beyond
downloading and using a third-party application.” 71 The idea behind pro-competitive implication
is that pro-competitive practices “promote the efficient access to, exchange of, and use of
electronic health information to support a competitive marketplace that enhances consumer value
and choice of direct-to-consumer technology, health coverage and care.” 72
Seemingly, CMS believes that by creating a need and a market for APIs, more APIs will
be developed. Within this competition to create them quickly and effectively, there will emerge
better, lower-cost APIs. This strategy may also address the current problem providers face because
there is little compatibility between and among different formats of healthcare data. This problem
is due in large part to the fact that the EHR companies “have little incentive to make it easy to

68
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share data with providers who use their competitors’ software.” 73 CMS distinguishes two types of
interoperability that it intends to promote with the rule: technical interoperability and semantic
interoperability.74 Technical interoperability refers to the capability of systems to “connect and
exchange” data without alteration, and semantic interoperability refers to the capability of systems
to “interpret and use” the data that has been exchanged. 75 The goal is to achieve both of these
objectives simultaneously.76
Under the rule, the open API must include: “adjudicated claims (including cost);
encounters with capitated providers; provider remittances; enrollee cost-sharing; clinical data,
including laboratory results.”77 The API should also include other information patients need to
easily access care, such as a provider directory so that patients can easily select a doctor within
their network.78 There are practical limits to updating this information and while insurance
providers face penalties for inaccuracies in the directories, 79 providers themselves are under no
penalty for being unresponsive to inquiries from patients. It is unclear if the implantation of this
data into APIs would remedy this problem, it should certainly be a goal. This data must be updated
“no later than one (1) business day after a claim is adjudicated or the encounter data is received by
the plan” because the immediacy/timeliness of the updates is a crucial part of allowing providers
to make determinations and to keep patients updated, as the rule intends to. 80 Because one day is
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not a long period of time, the practical limits of the requirements become relevant to the
effectiveness of the overall stated purpose. 81 This information can be used, in theory, to better
aggregate a patient’s data and to prioritize research that will assist in detecting diseases earlier and
more accurately.
IV.

Other Benefits

When patients have access to all of the data in their medical records, they can take that data
“with them from doctor to doctor, or to their other health care providers” more easily because they
would already have access to it in a format that belongs to them. 82 This would not only mean that
patients can choose a doctor that is available to them and meets their needs, but this would also
“give that provider secure access to their data, leading to greater competition and reducing costs.” 83
Immediate access to data lessens the burden on patients because if they wish to take their medical
records to a new doctor, they do not have to wait for their provider to compile the records, print
them, and then pick them up. They also will not have to pay the cost of printing or compiling the
records.
The move toward interoperability will also assist in the healthcare industry’s shift to
“value-based payments.”84

“Value-based payment” models focus on rewarding hospitals,

physicians, and other providers “for delivering high-quality health care” by tying payment to
value.85 As the name aptly suggests, payments are based on value: the monetary amount providers

81
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receive is directly tied to the quality of the healthcare they provide to patients. 86 The “value” is
measured by certain benchmarks, and in some “bundled care” arrangements, providers are
encouraged to work as a team with a network of other providers to deliver the care efficiently
together.87 If, for instance, a patient needs to attend physical therapy prior to or after undergoing
a surgical operation, a value-based payment model is one in which the surgeon and physical
therapist work together to coordinate the patient’s care and to ensure the patient makes a full
recovery, within a specified time frame, in order to receive a higher level of payment. Essentially,
the providers receive a bonus payment for ensuring the patient receives care quickly, but without
sacrificing the quality of the care they receive. The incentive works to lower healthcare costs
overall by preventing unnecessary visits to multiple providers and to ensure better patient care
through coordination between and among providers.88

As more insurers are beginning to

incorporate value-based payment models and other alternative payment models, there is a need to
better facilitate the exchange of patient data to meet the benchmarks outlined in the payment
structures.89 Interoperability would assist this goal by allowing all providers involved in the
administration of care to access and update patient information, and would similarly allow the
insurer or payer to monitor the patient’s progress on an active basis. 90

86
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Most importantly, the API platform can be utilized to prioritize certain findings within a
patient’s medical records.91 If providers work with software developers to prioritize data based on
certain symptoms, the patient’s age, or their medical history, this could ease the burden on
providers to look back at the patient’s entire medical history before making a diagnosis and
recommendation.92 For example, “a vendor can develop software that prioritizes a patient’s most
recent hospital visit over a negative colonoscopy.” 93 This would revolutionize the way that doctors
provide care and utilize their medical judgment when diagnosing patients. By employing an API
capable of analyzing the data and self-selecting important information, doctors could, in theory,
view a list of different diagnoses proposed by the software and then decide the best course of
treatment. While in many cases this may automatically present a solution, doctors could also use
the information gleaned by the API to employ additional tests to confirm the diagnosis.
The API would work by combining a patient’s symptoms and her test results or vital signs
to categorize possible medical diagnoses. By automating this crucial function, providers can more
accurately treat patients and screen for more potential diseases by having all of the information in
one place. Instead of relying on a patient’s inevitably faulty memory, providers would be able to
search a patient’s complete medical record for other symptoms or potential complications and
ascertain with better precision the proper diagnosis and course of treatment for the patient.
Because the data would be automatically prioritized for the provider, this could lessen provider
response time. It could also allow for providers to “create high-risk alerts for certain patients,”
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and run the data through the software to eliminate care options and select the best one for the
patient, perhaps by also including the patient’s history into the care analysis. 94
The COVID-19 pandemic has brought pre-existing conditions to the forefront of our minds
and the news cycle. This emphasis on increasing awareness about which demographics are most
at-risk to contract the coronavirus is a real-life example of how this tool could work to help identify
diseases sooner and to proactively treat patients. As the CDC gathers more information from
patients who have contracted coronavirus, it can better identify which patients are at a heightened
risk. This seems elementary, given what we know now, but when the first cases of the virus were
spreading, the lack of information greatly contributed to its transmission. This example highlights
how important it is—now more than ever—to use the power of data to help people stay healthy or
to recover from illnesses.
V.

Perceived and Actual Barriers to Implementation

There are difficulties associated with fully implementing interoperability and there is
uncertainty among providers about their ability to comply with both the interoperability rule and
HIPAA. This can be dealt with simply by understanding what HIPAA is and what it is not. HIPAA
was passed to help protect and safeguard the security and confidentiality of a person's health
information.95 One part of HIPAA, the Privacy Rule, aims to keep a patient’s medical information
private and prevent unnecessary disclosures of his or her PHI. 96 That certainly does not mean that
a doctor can never talk to anyone about a patient’s health information—doctors can still disclose
a patient’s PHI without his or her express written consent in many situations, especially if it is
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related to treatment, payment, or health care operations. 97 For example, if a patient has a heart
attack, his doctor has to inform his insurance company in order to receive payment, but his credit
card company does not have to be told about it. 98 If that same patient fell behind in paying his
medical bills, that fact can be reported to credit agencies (but they cannot identify which bills or
for which procedures the patient has yet to pay).99 Under HIPAA, PHI is considered to be
individually identifiable information relating to the past, present, or future health status of an
individual that is created, collected, or transmitted, or maintained by a HIPAA-covered entity in
relation to the provision of healthcare, payment for healthcare services, or use in healthcare
operations (PHI healthcare business uses).100 This includes “diagnoses, treatment information,
medical test results, and prescription information,” as well as “national identification numbers and
demographic information such as birth dates, gender, ethnicity, and contact and emergency contact
information.”101 This means that entities not covered by HIPAA are not required to safeguard PHI
and are not subject to penalties for mishandling it.102 If all personal identifiers are stripped from
health data, it ceases to be protected health information and the HIPAA Privacy Rule’s restrictions
on uses and disclosures no longer apply.103 In the context of interoperability, however, all
information uploaded and updated would be covered by HIPAA because it is all being handled by
HIPAA-covered entities.
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To finance healthcare, administer benefits, and check benefit eligibility, a health insurer
may, and always does, access medical records. 104 Improper use or access of data, outside of this
limited scope, would be considered a breach. 105 It is a myth that a healthcare provider is required
by law to provide all medical records to a patient when they exercise their right to request a copy
of their records.106 This exception serves as an additional protection for patients—if a doctor
believes a patient’s records will prove harmful (or if a doctor suspects a patient might inflict selfharm after viewing the records) then a doctor may deny the patient access. 107 Providers are not
required to correct errors found in patient records—however, patients may request changes to their
records.108 Patient access to medical records is therefore essential—without access, patients will
be unable to identify mistakes or request corrections. According to a 2016 study by Johns Hopkins,
an estimated 250,000 patients die each year as a result of “diagnostic errors and medical
mistakes.”109 Ross Kopel, a Health IT academic, estimates that nearly seventy percent of patient
medical records contain mistakes.110 Many of these errors are “irrelevant to health outcomes,”
such as listing that a patient twisted her ankle “on a Thursday, when it was in fact, Friday.” 111
Even when these mistakes are not acutely fatal, it is possible that many mistakes or
instances when doctors accidentally overlook critical data for the patient’s care do prevent patients
from being diagnosed at an early stage. Particularly with cancer diagnoses, the importance of early
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detection and prevention is the single most important factor to a patient’s chances of survival.
Interoperability would serve to curb this problem by allowing patients to actively monitor their
EHR and to prevent inaccuracies from impacting the care they receive. While a patient may not
remember what she told her physician during a yearly physical four years prior, she will ostensibly
remember quite well what she told her doctor earlier in the day, the week, or the month.
By enabling patients to take an active role in monitoring their own records, not only will it
ensure better accuracy, but it will also create an additional mechanism by which fraudulent claims
can be identified, thereby combating rising healthcare costs in the aggregate. 112 In cases where
providers may be inclined to alter medical records to reflect (and then bill for) services not actually
rendered, the ability of patients to monitor their health records and claims data will function as a
deterrent. The lack of patient involvement in medical record maintenance can pose serious
problems during the administration of their health benefits. Even if a patient has coverage for a
service, their health insurer may deny a portion of a claim or an entire claim simply because the
information provided by the doctor (or the lack thereof) negates the needs for the insurer to pay
for it. This is only one of many examples of how mistakes in medical records can pose problems
for patients. Because patients trust their providers to upload the information correctly, they have
little ability to check that the information is correct. For example, a patient may have his or her
information mistakenly placed in another person’s file, such as a sibling’s file, or another family
member. A provider could mistakenly update a patient’s information twice, to reflect a procedure
they only had once and should have been covered for the first time, but their insurance may refuse
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the second. By allowing patients to actively check this information as it is uploaded, rather than
after a problem arises with it, there will be fewer issues with which to deal.
In addition to easing access for patients, the Final Rule purports to champion ease of access
for providers. In anticipating a problem that will arise through the initial implementation of the
API, CMS has offered guidance on how to connect the many pieces of claim data and healthcare
records that an individual patient will have (in the absence of the ability to implement a Universal
Patient Identifier (UPI)).113 The use of a UPI would be similar to a license plate number or a
driver’s license number, where each person has a unique combination of letters and numbers. 114
The main concern with UPIs is that they are easy to identify, once standardized, and lack the
requisite security.115 If every hospital, doctor’s office, and healthcare insurance company suddenly
organizes patient files simply by a string of letters and numbers, it may be easier to compromise. 116
Instead, CMS proposes the use of “patient-matching,” a process whereby demographic and other
unique information is used to match the data to the patient. 117
Another potential barrier to complete implementation of interoperability relates to the
Substance Abuse and Mental Health Services Administration (SAMSHA).118 As a federal agency
established by Congress in 1992 within the U.S. Department of Health and Human Services that
“leads the public health efforts to advance the behavioral health of the nation,” 119 SAMSHA
recently released a final rule, known as 42 CFR Part 2, which modernized the confidentiality
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requirements for substance use disorder (SUD) patient records. 120 “Previously, Part 2 applied to
disclosures that ‘would identify a patient as an alcohol or drug abuser.” 121 Now, Part 2 applies to
SUDs, which are defined as “a cluster of cognitive, behavioral, and physiological symptoms
indicating that the individual continues using the substance despite significant substance-related
problems such as impaired, control, social impairment, risky use, and pharmacological tolerance
and withdrawal.”122 This definition does not include tobacco or caffeine use. In commentary,
SAMHSA provides examples such as “alcohol, cannabis, hallucinogens, inhalants, opioids,
sedatives, hypnotics, anxiolytics, and stimulants.”123 Under Part 2, a Part 2 Program must obtain
written patient consent to disclose information related to SUD treatment. 124 The consent must
contain: “the patient’s name; the part 2 program permitted to make the disclosure; the amount and
kind of SUD-related information to be disclosed; and the name of the individual or entity that is to
receive that information.”125 While “tracking disclosures may prove to be burdensome to Part 2
Programs,”126 this heightened level of privacy for patient information aligns with the sensitive
nature of SUD treatment and should be afforded to all patients seeking SUD treatment that wants
their information to remain private. The administrative burden is light in comparison to the burden
the patient could suffer if their private information was shared without their consent. It is also
worth noting that SAMHSA Part 2 is not synonymous with HIPAA. 127 Part 2 provides much more
stringent federal protections than are required under other health privacy laws. 128 “This suggests
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that providers risk non-compliance by relying solely on their HIPAA policies to safeguard Part 2
Program patients’ privacy.”129 In relation to interoperability, Part 2 seemingly requires informed
written consent to include this information in a patient’s EHR, which would be possible to
achieve.130 What is less clear, however, is if the patient must give written consent for each person
who may access the information.131 Even if a provider does not look at the particular record which
indicates a patient’s past SUD treatment, the fact that they have access to the information by virtue
of access to the API would seem to indicate that the patient should be able to dictate whether or
not they consent to such access. Although software programming may solve this by requiring
patient consent on an on-going basis, it is clear that this requirement is in direct conflict with the
affirmative requirement of the interoperability rule to disclose and make available all patient
information. Without a clearer understanding of the specific capabilities and features of the API,
the importance of patient privacy should trump the affirmative requirement to include the
information in the EHR.
There are also a variety of state-specific laws aimed at maintaining the confidentiality of
and protecting certain types of patient information that requires a heightened level of security.
These laws regulate, among other things, the use and storage of genetic information, pregnancy
and other women’s’ health information, and information pertaining to HIV/AIDS diagnoses.
Genetic information132 and a patient’s ability to control the use and storage of his or her
genetic information is “at the heart of controlling and protecting an individual’s rights.” 133
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“Genetic Liberty” is defined as the personal control of all aspects of a person’s genetic make-up,
including genetic material and information. 134 There are a variety of laws between and among the
United States which dictate how genetic tissue may be collected, stored, and used for research and
disease prevention.135 Most state legislatures have enacted legislation with the purpose and effect
of safeguarding genetic information at a heightened level than other types of health information. 136
This approach, known as genetic exceptionalism, “calls for special legal protections for genetic
information as a result of its predictive, personal and familial nature and other unique
characteristics.”137 Some commentators argue in favor of treating genetic information the same as
other health information because “genetic information is simply another form of health
information and is, therefore, difficult to distinguish from other health information, all of which
deserves equal protection under the law.” 138 With respect to privacy, Washington is the only state
that explicitly complies with this approach by treating genetic information the same as other health
information.139 It does so simply by including genetic information in the definition of health care
information under the state health privacy law.140 This means that every piece of information in a
patient’s medical record is confidential and requires express written consent for disclosure. While
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a total of twenty-six states require written consent to disclose genetic information, only seven states
require written consent to retain that same information. 141 Perhaps even more alarming, of the
twenty-six states that do require consent to disclose genetic information, only five define genetic
information as personal property—belonging to the person from whom it is extracted. 142 The
inclusion of genetic information in a patient’s EHR poses a problem similar to that presented with
SUD treatment information—in those states which require specific consent, it is unclear whether
the API will contain the necessary functions to comply with state-specific privacy laws. It is
unclear whether there will be a method by which the API monitors the location from which the
information is accessed. Ideally, it will include a mechanism by which the sensitive information
is secured and only viewable by providers to whom patients have expressly granted access.
Information regarding HIV/AIDS diagnoses and treatment are typically subject to
heightened scrutiny and pose similar problems to those discussed in connection with genetic
information. Virtually all states have enacted some HIV-specific statutes, many of which concern
information collection and protection either directly or indirectly. 143 “Twenty-three states classify
HIV/AIDS as a separate category of disease, sixteen classify it as a communicable disease, and
twelve as a sexually transmitted disease.” 144 All states require reporting of AIDS cases to the state
or local health department, and forty-one states also require reporting of HIV infection. 145 Much
like the limited-scope disclosure allowed by HIPAA, forty-eight states allow for disclosure of
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HIV-related information in certain proscribed circumstances. 146

The most commonly cited

permissible disclosures relevant to interoperability are to: a health care provider involved in the
patient’s care (43); blood banks or organ donors (22); epidemiologists and researchers (22);
HMOs, health care institutions, or mental health facilities (14); and insurance companies (8). 147
Some disclosure provisions require that patient-identifying information be removed from the data,
which would not be consistent with the goal of interoperability, but would be consistent with
patient privacy goals.148 “Thirty-eight states report statutory requirements for specific consent for
HIV testing including consent to the release of information.” 149
Conversely, just because a state lacks an HIV-specific consent statute does not necessarily
mean that informed consent is not required in a particular state. 150 Informed consent may be
required by other statutes, common law, regulations or policies. 151 Consistent with, but reaching
farther than, the stated objectives of HIPAA, “[f]orty-five states have either criminal or civil
penalties for unauthorized disclosure of HIV related information. 152 Thirty-three states have
criminal penalties, thirty-three have civil penalties and twenty-one provide for both civil and
criminal penalties.”153 For providers tasked with updating the health information of their patients
in order to comply with the interoperability rule, and tasked with safeguarding the privacy of their
patients’ most sensitive information, there is no clear path forward. Compliance with both rules
is seemingly impossible—and providers are forced to face potential civil and/or criminal penalties
for including a patient’s information in his or her EHR. This seems antithetical to the stated
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objectives behind interoperability. The point of creating the open API is to ease the burden on
providers, not to force them to choose which laws to break and which to obey.
VI.

The Role of the Internet

The California Consumer Privacy Act (CCPA) was passed with the intention of “holding
businesses accountable for data protection through strict guidelines and threatening consequences,
the new California privacy act is setting the foundation for US data privacy in 2020.” 154 For
patients who reside in California and wish to access their health information via the open API
structure, the CCPA would seemingly limit how they and their providers access and upload that
data. The CCPA “outlines new standards for data collection, new consequences for businesses
that fail to protect user data, and new rights that California consumers can exercise over their
data.”155 According to the CCPA, “businesses” that collect “consumer” data are subject to the
heightened regulations.156 Under the CCPA, a “consumer” is defined simply as a California
“resident” and a “business” is defined as a “for-profit entity that collects ‘consumer’ data” and has
either: an annual gross revenue over $25 million; or annually buys, receives, sells or shares the
personal information of 50,000 or more consumers, households, or devices for commercial
purposes; or derives fifty percent or more of its annual revenue from selling consumer personal
information.157 By that definition, every healthcare insurer that provides health insurance to
50,000 or more California residents is a “business” subject to the heightened regulations. While
it is unlikely that a single doctor would satisfy the definition of business, it is possible that a
hospital group or network of providers could ostensibly meet the two-pronged “business” test. The
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Act,
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18,

2019),

CCPA applies to all businesses—regardless of the headquarters of the business, itself. 158 This is
perhaps the most important aspect—because all insurers that collect data must comply with the
regulations outlined in the CCPA.
Personal information under the CCPA means “information that identifies, relates to,
describes, is reasonably capable of being associated with, or could reasonably be linked, directly
or indirectly, with a particular consumer or household” and includes other categories such as
biometric information, IP addresses, and inferences drawn about a consumer related to their
preferences, predispositions, and psychological trends. 159 Importantly, the CCPA includes an
exemption for protected health information collected by a covered entity or business associate
that is otherwise subject to HIPAA, but because this is not an “entity-wide exemption” it does
not entirely eliminate an insurance provider’s obligations under the Act. 160 Insurance companies
must still do their due diligence to identify the categories of consumers for whom they collect
information and “determining whether they fall under an exemption to the law.” 161 Though
insurance companies will not be “selling” patient data in order to make it accessible in
accordance with the interoperability rule, it is important that they update contracts with their
service providers to ensure compliance with the CCPA.162
The purpose underlying the CCPA is, as the name suggests, to give more rights to
individuals in furtherance of consumer privacy objectives. It gives individuals a list of enumerated
rights, all of which concern the access, transfer, editing, and deletion requests of their data. 163 It
establishes greater consequences for businesses that fail to adequately protect data and shifts
158
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accountability for data protection onto businesses that collect and handle user information—both
of which match up well with the rule’s goals to empower patients and incentivize providers to
generate more patient-friendly solutions.164 On its face, the CCPA is seemingly perfectly aligned
with the goals outlined in the interoperability rule. Upon closer inspection, however, it is tough to
reconcile some of the other rights the CCPA grants with the Final Rule. For example, the CCPA
gives consumers the ability to opt-out of certain data-processing practices. 165 Again, insurers and
providers who fall into the category of “businesses” under the CCPA are faced with almost an
impossible choice—comply with either the interoperability rule or the CCPA. According to the
CCPA text, Californians are now entitled to “know what information is being collected about
them; to know if their personal information is sold or disclosed, and to whom; to say ‘no’ to the
sale of personal information; to access their personal information; and to equal service and price,
even if they exercise their privacy rights.”166 Because the interoperability rule does not squarely
address the way in which the CCPA interacts with the stated requirements, it is tough to know how
to proceed.
For health care providers and insurers, the CCPA means they must comply with more statespecific laws than simply those of state in which they reside.

If their patients, enrollees,

beneficiaries, etc. travel to or live in a state with different privacy laws than the provider’s home
state, it is unclear how the interoperability rule changes the requirements. Under statutes like the
CCPA, however, it would appear they need to comply with those requirements as well as their
home state requirements. This is possible, albeit difficult. With proper guidance from CMS, it
should be possible to simultaneously comply with multiple rules. Because all of these rules are
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aimed at increasing patient privacy rights and granting access within the existing framework,
compliance is possible. It may take time, but CMS is optimistic that the right API can and will be
developed and that it will enable interoperability, so that providers may remain focused on giving
the best healthcare possible to their patients. This further highlights the aforementioned key role
that the API plays, despite the fact that it has not yet been established.
VII.

Potential Solutions

It is important to note that just because patients may be granted “access” to their data—the
affirmative requirement for providers to disclose such information is not accompanied by
heightened security or privacy measures. Patients (aside from those residents in California who
have a private right of action under the CCPA) still do not have any actionable legal right or remedy
for the misuse or impermissible disclosure of their health information. This transitional period
while developers are creating the open API brings a heightened chance of healthcare data breach.
Lacking any private right of action under HIPAA, patients are in no position to protect themselves
from over-zealous providers and insurers who are still acclimating to this new structure. While
the benefits of interoperability certainly outweigh the initial burdens associated with
implementation, it is important to keep in mind that this rule was passed for, and its implementation
and continued use should be tailored to, individual patients whose health and privacy depend on
it. In addition, it is important to note that COVID-19 already has and will continue to increase
pressure on our healthcare system. In response to the drastic changes that COVID-19 has caused,
CMS is considering delaying the implementation of the interoperability rule and will offer
enforcement leniency for various deadlines within the bill. 167
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Because the main goal of interoperability is to make patient data available, more
protections are needed to ensure that patient data is not subject to breach or misuse without
recourse. As written and enacted, the rule does little to actually equip patients with anything
other than their data. It does not have a private right of action, such as the one included in the
CCPA. This means that patients whose PHI or other data is subject to a breach have no new
legal protections. Advocates for greater patient privacy protection have noted that because of the
rule, “a lot more data, both covered and not covered by [HIPAA], will be available in the
wild.”168 “A lot more” is putting it lightly. Currently, 67.7 million Americans are enrolled in
Medicare,169 and 70.7 million Americans are enrolled in Medicaid and CHIP. 170 As the
Coronavirus pandemic continues to threaten the health, employment, and finances of millions of
Americans, these enrollment numbers and sure to rise.171
The need for increased privacy protections, however, does not stem from an increase in
enrollment. This need stems from the existing privacy landscape and the rule itself. By enlisting
the help of vendors to develop the APIs on which patients will eventually access their data, CMS
has failed to account for the privacy risks this poses for patients at an individual level. This is
precisely because the rule “lacks the necessary guardrails to protect consumers from actors such
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as third-party apps that are not required to meet the same stringent privacy and security
requirements as hospitals.”172
In response to this obvious shortcoming, Congress must amend HIPAA to explicitly
include these third-party apps as covered entities. The Trump administration and CMS have
addressed privacy-related concerns by assuring stakeholders “they will take privacy into
account,”173 and that “it is taking steps to let payers and patients protect their information.” 174
These steps include asking “third-party application developers to attest to certain privacy
provisions” and educating “enrollees about sharing health information with third parties.” 175
According to HHS, however, “third-party apps that are developed outside of a HIPAA-covered
entity are not subject to HIPAA rules even if a breach occurs.” 176 Simply asking vendors to
comply without any potential criminal or civil liability for failing to do so is not
enough/completely juvenile. Likewise, educating patients is not enough without equipping them
with a source of legal recourse in the even that their information is misused.
Given the purpose of the rule and the enforcement power that CMS holds, it is inapposite
to place the onus on a patient to know whether or not or for which purpose they should give their
most sensitive health information to a third-party app. I do not mean to undercut the ability or
knowledge of patients—I merely mean that patients should not be forced to choose between
better access to their health data and the protections afforded by the law. They should be able to
have both knowledge and legal protection, and it is up to Congress to make that happen. If the
success of this rule and the future of interoperability rely on the APIs and third-party apps, there
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is no reason why those entities should not be accountable the way that hospitals, providers,
insurers, and their business associates are. By this I mean, if they play such a crucial role in
enabling patient access to data, there should be liability for mishandling that information or
compromising its confidentiality.
In addition, Congress should amend HIPAA to clearly include a private right of action.
This would enable patients who suffer injuries as a result of a data breach by a covered entity to
be made whole. A private right of action would further incentivize the entities that handle EHR
to take extra measures to safeguard patient information. By placing the burden of compliance of
payers, providers, and the third-party apps without additionally granting individual rights, patients
do not have adequate privacy protection. Though the idea of adding a private right of action under
HIPAA has garnered a plethora of reactions ranging from full support to condemnation, newer,
more comprehensive privacy statutes like the CCPA and the GDPR in Europe do include private
causes of action. The CCPA has not been enacted long enough to definitively determine whether
the creation of a private right of action has caused a noticeable increase in cases or significantly
burdened the courts, as opponents of creating a private cause of action suggest. Though oft-cited,
there are practical limitations in place that will limit—if not entirely dispel—the proverbial
“flooding of the courts” that critics often warn against.
The most obvious safeguard against this concern has plagued privacy advocates and those
attempting to bring privacy-based claims for many years: standing requirements. In order to bring
a claim for anything, including a proposed private right of action under HIPAA, a plaintiff must
meet Article III Standing requirements. To have standing to sue, a plaintiff must have “(1) suffered
an injury in fact, (2) that is fairly traceable to the challenged conduct of the defendant, and (3) that
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is likely to be redressed by a favorable judicial decision.” 177 Standing requirements have long
served as a barrier to bringing superficial claims, and in the privacy context in particular, they have
prevented plaintiffs from bringing claims where they suffered no injury in fact. The need for a
private right of action is most obvious particularly where CMS and the Trump administration state
that they are encouraging app developers to create and implement privacy policies. While privacy
policies are a good start, they do not equip patients with sufficient standing for redress suffered as
a result of a health data breach.178 This is due especially to the fact that data breaches are unlike
other forms of tangible injury—once the data has been breached, it cannot simply be put back in a
patient’s file. Those patients whose information is misused and who suffer as a result of that
breach deserve the ability to pursue that harm the same way that a person who suffers a tortious
injury is able to.
Other critics have pointed to congressional intent (or rather, the lack thereof) as a reason
not to implement or infer a private right of action.179 While it is true that the statute as written
does not include any means by which private enforcement may occur, it is also true that when
Congress enacted HIPAA in 1996 it had no way of knowing what the health data privacy landscape
would look like almost a quarter of a century later. When Congress amended HIPAA in 2006 to
allow HHS enforcement, it similarly could not predict with any certainty what the data privacy
landscape would evolve into. The push toward interoperability has occurred much more recently,
and with this major change comes the need for other changes, namely, more protection and more
enforcement. As new data privacy risks emerge, and as legislation changes, Congress now has
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both the understanding and the opportunity to fill in the gaping holes that this changing landscape
exposes.
VIII. Conclusion
It is possible that the perfect API can be developed to allow compliance with a plethora of
laws and objectives. Given the advancement of technology and the incentivization that the rule
provides, the healthcare industry will inevitably generate solutions to these problems as they arise.
Although it will be costly to initially implement, the API will eventually lower the costs of
healthcare by decreasing barriers to accessing the data and by enabling researchers to find cures
for diseases by better aggregating health data.
In terms of the lasting impact of the rule on patients, if the data can be prioritized or
stratified in a way that better predicts a patient’s health outcomes, then it would lead to better,
more informed diagnoses and hopefully lead to a healthier population. By involving patients on a
more consistent basis, they will ask better questions, be more involved in their care, and lessen the
chance that providers will miss a crucial piece of their care (because patients will be able to remind
them, or to ask questions, or to know when things have been incorrectly updated to their charts).
This approach helps foster a better system of checks and balances between the patient, provider,
and insurer. When patients, providers, and payers all have access to the same information and can
be directly involved in (and informed of) what is happening, there are more opportunities to correct
discrepancies and to catch the crucial information that is needed to make the best decision—both
for the patients’ physical health and financial benefit. Mere access to this data is not enough to
achieve the goals of interoperability—patients must be able to hold providers, payers, and vendors
accountable for any harm that mishandling of this sensitive information causes.
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